相关实验视频

Updated: Jan 6, 2026

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish

Published on: May 25, 2017

分析:严重酒精相关肝炎的死亡率趋势和危险因素

Mushfiqur R Siddique¹, Muzzafar Haque², Francisco Idalsoaga^3,4

¹Department of Internal Medicine, Jamaica Hospital Medical Center, New York, USA.

Alimentary pharmacology & therapeutics

|September 20, 2025

概括

严重酒精相关性肝炎 (sAH) 的短期死亡率仍然很高,在过去四十年中没有显著改善. 这凸显了对新型治疗方法和对SAH患者更好的预后工具的迫切需要.

科学领域:

肝病学肝病学是一种肝病学.
临床医学临床医学
公共卫生公共卫生

背景情况:

严重的酒精相关性肝炎 (sAH) 是一种危急的,危及生命的肝脏疾病.
尽管临床进展,SAH患者的预后仍然很差.
目前SAH疗法的长期疗效尚未得到充分证实.

研究的目的:

在五十年内系统地审查和分析sAH的短期死亡率趋势 (28,60,90天).
为了识别随着时间的推移,SAH死亡率的变化和模式.
评估临床管理对SAH结果的影响.

主要方法:

在PubMed,EMBASE和Scopus进行了系统的文献搜索,直到2024年2月.
使用随机效应元回归和贝叶斯模型计算了聚合死亡率估计.
使用I2统计数据评估异质性,并进行子组和元回归分析.

主要成果:

分析了34项涉及1586名SAH患者的研究.
在28日,60日和90日死亡率中,死亡率分别为26.8%,35.1%和43.7%.
尽管2000年后的早期死亡率下降,但近几十年来没有观察到总体短期死亡率的统计学上显著改善;MELD得分是一个重要的预测因素.

结论:

与酒精相关的严重肝炎的短期死亡率仍然不可接受地高.
在过去的几十年中,SAH短期死亡率没有显著改善.
紧急开发有效的疗法,改善肝移植选择和增强的预后工具对于SAH管理至关重要.

关键词:

酒精酒精酒精酒精酒精酒精酒精酒精性肝硬化酒精性肝硬化酒精性肝炎是一种酒精性肝炎.酒精性肝病是一种肝病.与酒精相关的肝病.进行元分析,进行元分析.死亡率死亡率系统性审查系统性审查

更多相关视频

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Author Spotlight: Evaluating Therapeutic Strategies to Enhance Liver Regeneration

Author Spotlight: Evaluating Therapeutic Strategies to Enhance Liver Regeneration

Published on: May 24, 2024

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...

Hypothesis Test for Test of Independence

Hypothesis Test for Test of Independence

The test of independence is a chi-square-based test used to determine whether two variables or factors are independent or dependent. This hypothesis test is used to examine the independence of the variables. One can construct two qualitative survey questions or experiments based on the variables in a contingency table. The goal is to see if the two variables are unrelated (independent) or related (dependent). The null and alternative hypotheses for this test are:
H0: The two variables (factors)...

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...

Diseases of the Liver and Gallbladder

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...